Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001700205-24-000005·Auctus Fund Management LLC
Schedule 13G ownership disclosure
GUIDED THERAPEUTICS INCORPORATED
Common Stock, par value $0.001 per share · CUSIP: 40171F501
Event date: 2024-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Auctus Fund Management LLC
Shares: 5,804,865.00 · Class: 9.9%
- Auctus Fund, LLC
Shares: 5,804,865.00 · Class: 9.9%
- Alfred Sollami
Shares: 5,804,865.00 · Class: 9.9%
- Louis Posner
Shares: 5,804,865.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001700205-24-000005
- Form type
- SCHEDULE 13G/A
- Filer
- Auctus Fund Management LLC
- CIK
- CIK 1700205
- Filed
- Nov 14, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership